Evolva Holding (Switzerland) Performance
EVE Stock | CHF 0.86 0.02 2.27% |
Evolva Holding has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.42, which means possible diversification benefits within a given portfolio. As returns on the market increase, Evolva Holding's returns are expected to increase less than the market. However, during the bear market, the loss of holding Evolva Holding is expected to be smaller as well. Evolva Holding SA right now shows a risk of 5.16%. Please confirm Evolva Holding SA total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if Evolva Holding SA will be following its price patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Evolva Holding SA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, Evolva Holding may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Begin Period Cash Flow | 19.7 M | |
Total Cashflows From Investing Activities | -4.6 M |
Evolva |
Evolva Holding Relative Risk vs. Return Landscape
If you would invest 84.00 in Evolva Holding SA on August 28, 2024 and sell it today you would earn a total of 2.00 from holding Evolva Holding SA or generate 2.38% return on investment over 90 days. Evolva Holding SA is generating 0.1684% of daily returns assuming 5.1604% volatility of returns over the 90 days investment horizon. Simply put, 45% of all stocks have less volatile historical return distribution than Evolva Holding, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Evolva Holding Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evolva Holding's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Evolva Holding SA, and traders can use it to determine the average amount a Evolva Holding's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0326
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | EVE | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.16 actual daily | 45 55% of assets are more volatile |
Expected Return
0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Evolva Holding is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evolva Holding by adding it to a well-diversified portfolio.
Evolva Holding Fundamentals Growth
Evolva Stock prices reflect investors' perceptions of the future prospects and financial health of Evolva Holding, and Evolva Holding fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Evolva Stock performance.
Return On Equity | -0.37 | |||
Return On Asset | -0.11 | |||
Operating Margin | (2.31) % | |||
Current Valuation | 91.22 M | |||
Shares Outstanding | 1.11 B | |||
Price To Earning | (4.33) X | |||
Price To Book | 0.75 X | |||
Price To Sales | 7.35 X | |||
Revenue | 9.88 M | |||
EBITDA | (31.82 M) | |||
Cash And Equivalents | 11 M | |||
Cash Per Share | 0.08 X | |||
Total Debt | 3.57 M | |||
Debt To Equity | 1.60 % | |||
Book Value Per Share | 0.10 X | |||
Cash Flow From Operations | (29.79 M) | |||
Earnings Per Share | (0.05) X | |||
Total Asset | 156.17 M | |||
About Evolva Holding Performance
Evaluating Evolva Holding's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Evolva Holding has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Evolva Holding has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Evolva Holding SA discovers, develops, and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, United States, Denmark, and internationally. The company was founded in 2004 and is headquartered in Reinach, Switzerland. EVOLVA N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 67 people.Things to note about Evolva Holding SA performance evaluation
Checking the ongoing alerts about Evolva Holding for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Evolva Holding SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evolva Holding SA had very high historical volatility over the last 90 days | |
Evolva Holding SA has some characteristics of a very speculative penny stock | |
The company reported the revenue of 9.88 M. Net Loss for the year was (41.27 M) with loss before overhead, payroll, taxes, and interest of (8.81 M). | |
Evolva Holding SA has accumulated about 11 M in cash with (29.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. |
- Analyzing Evolva Holding's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Evolva Holding's stock is overvalued or undervalued compared to its peers.
- Examining Evolva Holding's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Evolva Holding's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Evolva Holding's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Evolva Holding's stock. These opinions can provide insight into Evolva Holding's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Evolva Stock Analysis
When running Evolva Holding's price analysis, check to measure Evolva Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolva Holding is operating at the current time. Most of Evolva Holding's value examination focuses on studying past and present price action to predict the probability of Evolva Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolva Holding's price. Additionally, you may evaluate how the addition of Evolva Holding to your portfolios can decrease your overall portfolio volatility.